chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Cold sweat, Decreased appetite, Feeling abnormal
Clinical narrative: cold sweat; cramp in kidney; lost appetite; feels fuzzy-headed; whole shoulder is sore; fever between 100 and 101 degrees F that has come and goes; chills; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (cold sweat), RENAL PAIN (cramp in kidney), DECREASED APPETITE (lost appetite), FEELING ABNORMAL (feels fuzzy-headed) and PAIN IN EXTREMITY (whole shoulder is sore) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0281A27A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, the patient experienced COLD SWEAT (cold sweat), RENAL PAIN (cramp in kidney), DECREASED APPETITE (lost appetite), FEELING ABNORMAL (feels fuzzy-headed), PAIN IN EXTREMITY (whole shoulder is sore), PYREXIA (fever between 100 and 101 degrees F that has come and goes) and CHILLS (chills). At the time of the report, COLD SWEAT (cold sweat), RENAL PAIN (cramp in kidney), DECREASED APPETITE (lost appetite), FEELING ABNORMAL (feels fuzzy-headed), PAIN IN EXTREMITY (whole shoulder is sore), PYREXIA (fever between 100 and 101 degrees F that has come and goes) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Apr-2021, Body temperature: high (High) High 100 to 101 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  Patient regained a small appetite on 13 Apr 2021, but had no appetite on 14 Apr 2021.  Treatment included tylenol.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Renal pain
Clinical narrative: cold sweat; cramp in kidney; lost appetite; feels fuzzy-headed; whole shoulder is sore; fever between 100 and 101 degrees F that has come and goes; chills; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (cold sweat), RENAL PAIN (cramp in kidney), DECREASED APPETITE (lost appetite), FEELING ABNORMAL (feels fuzzy-headed) and PAIN IN EXTREMITY (whole shoulder is sore) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0281A27A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, the patient experienced COLD SWEAT (cold sweat), RENAL PAIN (cramp in kidney), DECREASED APPETITE (lost appetite), FEELING ABNORMAL (feels fuzzy-headed), PAIN IN EXTREMITY (whole shoulder is sore), PYREXIA (fever between 100 and 101 degrees F that has come and goes) and CHILLS (chills). At the time of the report, COLD SWEAT (cold sweat), RENAL PAIN (cramp in kidney), DECREASED APPETITE (lost appetite), FEELING ABNORMAL (feels fuzzy-headed), PAIN IN EXTREMITY (whole shoulder is sore), PYREXIA (fever between 100 and 101 degrees F that has come and goes) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Apr-2021, Body temperature: high (High) High 100 to 101 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  Patient regained a small appetite on 13 Apr 2021, but had no appetite on 14 Apr 2021.  Treatment included tylenol.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Decubitus ulcer, Lymph node pain, Lymphadenopathy, Nodule, Skin mass
Clinical narrative: small little jelly bean that moves around under her skin; whole area swelled up a lot; more tender; felt a lot of pressure (like a punch and a bruise) that hurt so bad.; it is really puffy up there; she can feel a hard nodule underneath that moves; lymph nodes right above her left collarbone; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (lymph nodes right above her left collarbone), SWELLING (whole area swelled up a lot), LYMPH NODE PAIN (more tender), DECUBITUS ULCER (felt a lot of pressure (like a punch and a bruise) that hurt so bad.) and SKIN SWELLING (it is really puffy up there) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products were not provided.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced LYMPHADENOPATHY (lymph nodes right above her left collarbone). On 19-Mar-2021, the patient experienced SWELLING (whole area swelled up a lot), LYMPH NODE PAIN (more tender) and DECUBITUS ULCER (felt a lot of pressure (like a punch and a bruise) that hurt so bad.). On 14-Apr-2021, the patient experienced SKIN MASS (small little jelly bean that moves around under her skin). On an unknown date, the patient experienced SKIN SWELLING (it is really puffy up there) and NODULE (she can feel a hard nodule underneath that moves). At the time of the report, LYMPHADENOPATHY (lymph nodes right above her left collarbone), SWELLING (whole area swelled up a lot), LYMPH NODE PAIN (more tender), DECUBITUS ULCER (felt a lot of pressure (like a punch and a bruise) that hurt so bad.) and SKIN MASS (small little jelly bean that moves around under her skin) outcome was unknown. Not Provided   Treatment products were not provided.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Skin swelling, Swelling
Clinical narrative: small little jelly bean that moves around under her skin; whole area swelled up a lot; more tender; felt a lot of pressure (like a punch and a bruise) that hurt so bad.; it is really puffy up there; she can feel a hard nodule underneath that moves; lymph nodes right above her left collarbone; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (lymph nodes right above her left collarbone), SWELLING (whole area swelled up a lot), LYMPH NODE PAIN (more tender), DECUBITUS ULCER (felt a lot of pressure (like a punch and a bruise) that hurt so bad.) and SKIN SWELLING (it is really puffy up there) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products were not provided.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced LYMPHADENOPATHY (lymph nodes right above her left collarbone). On 19-Mar-2021, the patient experienced SWELLING (whole area swelled up a lot), LYMPH NODE PAIN (more tender) and DECUBITUS ULCER (felt a lot of pressure (like a punch and a bruise) that hurt so bad.). On 14-Apr-2021, the patient experienced SKIN MASS (small little jelly bean that moves around under her skin). On an unknown date, the patient experienced SKIN SWELLING (it is really puffy up there) and NODULE (she can feel a hard nodule underneath that moves). At the time of the report, LYMPHADENOPATHY (lymph nodes right above her left collarbone), SWELLING (whole area swelled up a lot), LYMPH NODE PAIN (more tender), DECUBITUS ULCER (felt a lot of pressure (like a punch and a bruise) that hurt so bad.) and SKIN MASS (small little jelly bean that moves around under her skin) outcome was unknown. Not Provided   Treatment products were not provided.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Rash, Swelling, Vaccination site pruritus
Clinical narrative: swelling; rash; arm started itching pretty bad; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling), RASH (rash) and VACCINATION SITE PRURITUS (arm started itching pretty bad) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced SWELLING (swelling) and RASH (rash). In April 2021, the patient experienced VACCINATION SITE PRURITUS (arm started itching pretty bad). At the time of the report, SWELLING (swelling), RASH (rash) and VACCINATION SITE PRURITUS (arm started itching pretty bad) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Little sore arm after first dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Little sore arm after first dose) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Cholesterol. Concomitant products included MELOXICAM and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (Little sore arm after first dose). At the time of the report, PAIN IN EXTREMITY (Little sore arm after first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details included Tylenol. Concomitant products included Blood pressure medicine, Cholesterol medicine.   This case was linked to US-MODERNATX, INC.-MOD-2021-076482 (E2B Linked Report).
Sex: F
Vaccine: COVID19
Symptoms: Aggression, Conversion disorder
Clinical narrative: patient became violent for nine days; patient became hysterical for nine days; This spontaneous case was reported by a consumer and describes the occurrence of AGGRESSION (patient became violent for nine days) and CONVERSION DISORDER (patient became hysterical for nine days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced AGGRESSION (patient became violent for nine days) and CONVERSION DISORDER (patient became hysterical for nine days). At the time of the report, AGGRESSION (patient became violent for nine days) and CONVERSION DISORDER (patient became hysterical for nine days) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient stated that she had similar reaction in the past when she received iodine in a medical substance. Concomitant medications were not reported. Treatment information in response to events was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Herpes zoster, Pyrexia, Rash
Clinical narrative: Shingles; Shingles; Felt weak; rash on half of the torso; Temperature, which was 99 degree; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Felt weak), the first episode of HERPES ZOSTER (Shingles), the second episode of HERPES ZOSTER (Shingles), RASH (rash on half of the torso) and PYREXIA (Temperature, which was 99 degree) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, the patient experienced ASTHENIA (Felt weak), RASH (rash on half of the torso) and PYREXIA (Temperature, which was 99 degree). On 05-Apr-2021, the patient experienced the first episode of HERPES ZOSTER (Shingles). On 12-Apr-2021, the patient experienced the second episode of HERPES ZOSTER (Shingles). The patient was treated with PARACETAMOL (TYLENOL) for Body temperature, at an unspecified dose and frequency. At the time of the report, ASTHENIA (Felt weak), the last episode of HERPES ZOSTER (Shingles), RASH (rash on half of the torso) and PYREXIA (Temperature, which was 99 degree) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Apr-2021, Body temperature: 99 (Inconclusive) Temperature, which was 99 degree.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nauseous) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced NAUSEA (Nauseous). At the time of the report, NAUSEA (Nauseous) outcome was unknown. Not Provided          The patient's medical history was not provided.  No relevant concomitant medications were reported. No treatment information was provided. The patient received both scheduled doses of mRNA-1273 prior to the events, therefore, the action taken with the drug in response to the events was not applicable.
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance
Clinical narrative: He could not walk, he is not able to walk; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (He could not walk, he is not able to walk) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     Concomitant products included OMEPRAZOLE for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced GAIT DISTURBANCE (He could not walk, he is not able to walk). At the time of the report, GAIT DISTURBANCE (He could not walk, he is not able to walk) outcome was unknown.            Concomitant medications for high blood pressure and heart were not specified.   This case was linked to MOD21-075816, MOD21-075779, US-MODERNATX, INC.-MOD-2021-076514, US-MODERNATX, INC.-MOD-2021-076575, US-MODERNATX, INC.-MOD-2021-076603 (E2B Linked Report).; Sender's Comments:  MOD21-075816:Crosslink MOD21-075779:Crosslink US-MODERNATX, INC.-MOD-2021-076514: US-MODERNATX, INC.-MOD-2021-076575:1st dose vaccine - husband US-MODERNATX, INC.-MOD-2021-076603:1st dose vaccine - husband
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Breast pain, Pain in extremity
Clinical narrative: pain on the left breast; sore arm; back is sore; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (pain on the left breast), PAIN IN EXTREMITY (sore arm) and BACK PAIN (back is sore) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     Concurrent medical conditions included Heavy menstrual bleeding (During vaccination) and Menstrual cycle abnormal (menstrual bleeding for three weeks).    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BREAST PAIN (pain on the left breast), PAIN IN EXTREMITY (sore arm) and BACK PAIN (back is sore). At the time of the report, BREAST PAIN (pain on the left breast), PAIN IN EXTREMITY (sore arm) and BACK PAIN (back is sore) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient did not inform her vaccination provider that she had heavy menstrual bleeding for three weeks at the time of vaccination. Concomitant medications were not reported. Treatment information in response to events was not provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Fatigue which is still continued and stopping her to do her regular activities; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue which is still continued and stopping her to do her regular activities) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced FATIGUE (Fatigue which is still continued and stopping her to do her regular activities). At the time of the report, FATIGUE (Fatigue which is still continued and stopping her to do her regular activities) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Hypercholesterolaemia (Cholesterol). Concomitant products included MELOXICAM and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 07-Apr-2021, PYREXIA (Fever) had resolved. Not Provided          Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-076474 (Patient Link).
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: She will not take the second vaccine; This spontaneous case was reported by a non-health professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (She will not take the second vaccine) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (She will not take the second vaccine). At the time of the report, PRODUCT DOSE OMISSION ISSUE (She will not take the second vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided. Treatment information was not provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow-up received and event stomach pain was removed as patient denied reporting any side effects.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Flushing, Musculoskeletal stiffness
Clinical narrative: hard tightness from the inner muscle of right shoulder all the way down to the palm; tightness in chest; face got little warm; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (hard tightness from the inner muscle of right shoulder all the way down to the palm), CHEST DISCOMFORT (tightness in chest) and FLUSHING (face got little warm) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METFORMIN, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), ATORVASTATIN, LISINOPRIL and METOPROLOL for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (hard tightness from the inner muscle of right shoulder all the way down to the palm), CHEST DISCOMFORT (tightness in chest) and FLUSHING (face got little warm). On 14-Apr-2021, MUSCULOSKELETAL STIFFNESS (hard tightness from the inner muscle of right shoulder all the way down to the palm), CHEST DISCOMFORT (tightness in chest) and FLUSHING (face got little warm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Pyrexia, Vomiting
Clinical narrative: Nausea; Through away; Chills; Fatigue; Fever; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), VOMITING (Through away), CHILLS (Chills), FATIGUE (Fatigue) and PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concurrent medical conditions included Seasonal allergy. Concomitant products included LORATADINE (CLARITINE) for an unknown indication.    On 11-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced NAUSEA (Nausea), VOMITING (Through away), CHILLS (Chills), FATIGUE (Fatigue) and PYREXIA (Fever). On 14-Apr-2021, NAUSEA (Nausea), VOMITING (Through away), CHILLS (Chills), FATIGUE (Fatigue) and PYREXIA (Fever) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: Follow-up information received contains no new significant information
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Heart rate, Throat tightness
Clinical narrative: Felt they would passed out; Throat closing up; Really dizzy; This spontaneous case was reported by a nurse and describes the occurrence of FEELING ABNORMAL (Felt they would passed out), THROAT TIGHTNESS (Throat closing up) and DIZZINESS (Really dizzy) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced FEELING ABNORMAL (Felt they would passed out), THROAT TIGHTNESS (Throat closing up) and DIZZINESS (Really dizzy). On 16-Mar-2021, FEELING ABNORMAL (Felt they would passed out), THROAT TIGHTNESS (Throat closing up) and DIZZINESS (Really dizzy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Mar-2021, Heart rate: 130 (High) Heart rate went up to 130.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that the patient was told to lay down and given some water and carbohydrates. Patient felt better and left the facility after an hour. Concomitant medications were not reported.
Age: 29.0
Sex: U
Vaccine: COVID19
Symptoms: Dysgeusia, Nausea, Pain, Pyrexia, Taste disorder
Clinical narrative: Metallicy; Sense of taste is distorted; Fever; Nausea; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Metallicy), TASTE DISORDER (Sense of taste is distorted), PYREXIA (Fever), NAUSEA (Nausea) and PAIN (Body aches) in a 29-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced PYREXIA (Fever), NAUSEA (Nausea) and PAIN (Body aches). On 13-Apr-2021, the patient experienced DYSGEUSIA (Metallicy) and TASTE DISORDER (Sense of taste is distorted). At the time of the report, DYSGEUSIA (Metallicy), TASTE DISORDER (Sense of taste is distorted), PYREXIA (Fever), NAUSEA (Nausea) and PAIN (Body aches) outcome was unknown.            Concomitant medications were not reported. Treatment details not provided Action taken with mRNA-1273 in response to the events was  not applicable
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: Little dizziness; Little nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Little dizziness) and NAUSEA (Little nausea) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included COPD. Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX) for an unknown indication.    On 14-Apr-2021 at 2:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced DIZZINESS (Little dizziness) and NAUSEA (Little nausea). At the time of the report, DIZZINESS (Little dizziness) and NAUSEA (Little nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Another concomitant medication included COPD medication. Treatment information in response to events was not provided.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Dizziness, Nausea, Vaccination site pain
Clinical narrative: dizzy; nauseas; discomfort; injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (discomfort), VACCINATION SITE PAIN (injection site pain), DIZZINESS (dizzy) and NAUSEA (nauseas) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031AZ1A and 030B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced DISCOMFORT (discomfort) and VACCINATION SITE PAIN (injection site pain). On 14-Apr-2021, the patient experienced DIZZINESS (dizzy) and NAUSEA (nauseas). At the time of the report, DISCOMFORT (discomfort), VACCINATION SITE PAIN (injection site pain), DIZZINESS (dizzy) and NAUSEA (nauseas) outcome was unknown.            This case was linked to MOD-2021-076506 (Patient Link).
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discomfort, Vaccination site pain
Clinical narrative: a sensation of pressure; soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (a sensation of pressure) and VACCINATION SITE PAIN (soreness) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Irritable bowel syndrome (IBS-D ( diarrhoea )).    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced VACCINATION SITE DISCOMFORT (a sensation of pressure) and VACCINATION SITE PAIN (soreness). On 15-Apr-2021, VACCINATION SITE DISCOMFORT (a sensation of pressure) and VACCINATION SITE PAIN (soreness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021: Updated the outcome of the events from unknown to recovered.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: Really bad headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Really bad headache) and FATIGUE (Fatigue) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 029A21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included LEVOTHYROXINE, ESTRADIOL, SERTRALINE, GABAPENTIN (NEURONTIN) and PROGESTERONE for an unknown indication.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced HEADACHE (Really bad headache) and FATIGUE (Fatigue). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) at an unspecified dose and frequency. At the time of the report, HEADACHE (Really bad headache) and FATIGUE (Fatigue) outcome was unknown. Not Provided          The patient noted that she did not normally get headaches, and that she experienced headache when she bent over and when she coughed specifically.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: contact details, concomitant medications and dosage information updated.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: severe pain in both legs; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (severe pain in both legs) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced PAIN IN EXTREMITY (severe pain in both legs). The patient was treated with PARACETAMOL (TYLENOL) for Leg pain, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (severe pain in both legs) had not resolved. Not Provided          No concomitant medications were reported.  For mRNA-1273 (COVID 19 Vaccine Moderna) (Unknown), the reporter did not provide any causality assessments Action taken with mRNA-1273 in response to the event was not applicable.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Oral discomfort, Pyrexia, Tinnitus
Clinical narrative: Face is numb; Tongue and mouth on fire; Ringing in ears; Numbness has spread to feet and arms; Fever; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Face is numb), ORAL DISCOMFORT (Tongue and mouth on fire), TINNITUS (Ringing in ears), HYPOAESTHESIA (Numbness has spread to feet and arms) and PYREXIA (Fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Face is numb), ORAL DISCOMFORT (Tongue and mouth on fire), TINNITUS (Ringing in ears), HYPOAESTHESIA (Numbness has spread to feet and arms) and PYREXIA (Fever). The patient was treated with AMITRIPTYLINE for Symptomatic treatment, at a dose of 1 dosage form. At the time of the report, HYPOAESTHESIA (Face is numb), ORAL DISCOMFORT (Tongue and mouth on fire), TINNITUS (Ringing in ears), HYPOAESTHESIA (Numbness has spread to feet and arms) and PYREXIA (Fever) outcome was unknown. Not Provided          No relevant concomitant medications were reported.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore, the action taken with the drug in response to the events was not applicable.
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: swelling in the arm of injection.; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling in the arm of injection.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swelling in the arm of injection.). At the time of the report, PERIPHERAL SWELLING (swelling in the arm of injection.) outcome was unknown.            No concomitant medication reported.  Treatment information not provided.  Action taken with mRNA-1273 in response to the events was not applicable.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Vaccination site pain
Clinical narrative: swollen lymph node; with dull pain; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen lymph node) and VACCINATION SITE PAIN (with dull pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (swollen lymph node) and VACCINATION SITE PAIN (with dull pain). At the time of the report, LYMPHADENOPATHY (swollen lymph node) and VACCINATION SITE PAIN (with dull pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The action taken with mRNA-1273 in response to the event was not applicable. No concomitant medication reported. No treatment was provided.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: Just started her period today after her vaccination/ not expecting her period for another 2 months; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of MENSTRUATION IRREGULAR (Just started her period today after her vaccination/ not expecting her period for another 2 months) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ETHINYLESTRADIOL, LEVONORGESTREL (SEASONIQUE) for Birth control.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced MENSTRUATION IRREGULAR (Just started her period today after her vaccination/ not expecting her period for another 2 months). At the time of the report, MENSTRUATION IRREGULAR (Just started her period today after her vaccination/ not expecting her period for another 2 months) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient was on quarterly birth-control medication.  No treatment information was provided.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Muscle tightness
Clinical narrative: numbness and tightness in her neck; numbness and tightness in her neck; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness and tightness in her neck) and MUSCLE TIGHTNESS (numbness and tightness in her neck) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (numbness and tightness in her neck) and MUSCLE TIGHTNESS (numbness and tightness in her neck). At the time of the report, HYPOAESTHESIA (numbness and tightness in her neck) and MUSCLE TIGHTNESS (numbness and tightness in her neck) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported No treatment medication were reported.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: follow-up document updated about event information
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Chills, Fatigue, Headache
Clinical narrative: Fatigue; Headache; Muscle pain; Joint pain; Chills; I would describe it like arthritis symptoms over my whole body because I have arthritis, but this; Every inch of my body ache, like internally.; Little of nausea; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), ARTHRITIS (I would describe it like arthritis symptoms over my whole body because I have arthritis, but this), PAIN (Every inch of my body ache, like internally.), NAUSEA (Little of nausea) and FATIGUE (Fatigue) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included MELOXICAM and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 06-Apr-2021, the patient experienced NAUSEA (Little of nausea). On 07-Apr-2021, the patient experienced ARTHRITIS (I would describe it like arthritis symptoms over my whole body because I have arthritis, but this), PAIN (Every inch of my body ache, like internally.), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and CHILLS (Chills). On 10-Apr-2021, ARTHRITIS (I would describe it like arthritis symptoms over my whole body because I have arthritis, but this), PAIN (Every inch of my body ache, like internally.), NAUSEA (Little of nausea), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and CHILLS (Chills) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Treatment medication were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-076515 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-076515:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pain, Pain in extremity
Clinical narrative: Fatigue; Headache; Muscle pain; Joint pain; Chills; I would describe it like arthritis symptoms over my whole body because I have arthritis, but this; Every inch of my body ache, like internally.; Little of nausea; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), ARTHRITIS (I would describe it like arthritis symptoms over my whole body because I have arthritis, but this), PAIN (Every inch of my body ache, like internally.), NAUSEA (Little of nausea) and FATIGUE (Fatigue) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included MELOXICAM and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 06-Apr-2021, the patient experienced NAUSEA (Little of nausea). On 07-Apr-2021, the patient experienced ARTHRITIS (I would describe it like arthritis symptoms over my whole body because I have arthritis, but this), PAIN (Every inch of my body ache, like internally.), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and CHILLS (Chills). On 10-Apr-2021, ARTHRITIS (I would describe it like arthritis symptoms over my whole body because I have arthritis, but this), PAIN (Every inch of my body ache, like internally.), NAUSEA (Little of nausea), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and CHILLS (Chills) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Treatment medication were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-076515 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-076515:
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Tachycardia
Clinical narrative: Sore arm; Fast heart beat; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and TACHYCARDIA (Fast heart beat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007b21a) for COVID-19 vaccination.     Concurrent medical conditions included Tetanus (allergic to tetanus shot). Concomitant products included PREDNISONE for an unknown indication.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and TACHYCARDIA (Fast heart beat). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and IBUPROFEN at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Sore arm) and TACHYCARDIA (Fast heart beat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-076537 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow up received on 10-May-2021. No new information added.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-076537:Dose 2
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: My arm was itching; Raised up rash the size of an egg, an un cracked egg; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (My arm was itching) and RASH (Raised up rash the size of an egg, an un cracked egg) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR), CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE (ATACAND HCT), BUPROPION HYDROCHLORIDE (WELLBUTRIN) and ALPRAZOLAM (XANAX) for an unknown indication.    On 06-Apr-2021 at 3:05 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced PRURITUS (My arm was itching) and RASH (Raised up rash the size of an egg, an un cracked egg). At the time of the report, PRURITUS (My arm was itching) and RASH (Raised up rash the size of an egg, an un cracked egg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient did not take any treatment medication.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: Dizzy/ off center; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy/ off center) and NAUSEA (Nausea) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 031AZ(or2)1A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced DIZZINESS (Dizzy/ off center) and NAUSEA (Nausea). At the time of the report, DIZZINESS (Dizzy/ off center) and NAUSEA (Nausea) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.    This case was linked to MOD-2021-076491 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: hair loss; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (hair loss) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced ALOPECIA (hair loss). At the time of the report, ALOPECIA (hair loss) outcome was unknown. Not Provided          No concomitant medication were reported. No treatment medication details were reported. The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow-up received on 07-MAY-2021. additional information: patient demographics